RayzeBio Balance Sheet Health
Financial Health criteria checks 6/6
RayzeBio has a total shareholder equity of $575.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $603.5M and $28.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$540.17m |
| Equity | US$575.32m |
| Total liabilities | US$28.19m |
| Total assets | US$603.51m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RYZB's short term assets ($545.0M) exceed its short term liabilities ($17.1M).
Long Term Liabilities: RYZB's short term assets ($545.0M) exceed its long term liabilities ($11.1M).
Debt to Equity History and Analysis
Debt Level: RYZB is debt free.
Reducing Debt: RYZB has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RYZB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: RYZB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 53.5% each year